Efficacy of an Electronic Cognitive Behavioral Therapy Program Delivered via the Online Psychotherapy Tool for Depression and Anxiety Related to the COVID-19 Pandemic: Pre-Post Pilot Study

JMIR Ment Health. 2023 Dec 25:10:e51102. doi: 10.2196/51102.

Abstract

Background: Lockdowns and social distancing resulting from the COVID-19 pandemic have worsened the population's mental health and made it more difficult for individuals to receive care. Electronic cognitive behavioral therapy (e-CBT) is a cost-effective and evidence-based treatment for anxiety and depression and can be accessed remotely.

Objective: The objective of the study was to investigate the efficacy of online psychotherapy tailored to depression and anxiety symptoms during the pandemic.

Methods: The pilot study used a pre-post design to evaluate the efficacy of a 9-week e-CBT program designed for individuals with depression and anxiety affected by the pandemic. Participants were adults (N=59) diagnosed with major depressive disorder and generalized anxiety disorder, whose mental health symptoms initiated or worsened during the COVID-19 pandemic. The online psychotherapy program focused on teaching coping, mindfulness, and problem-solving skills. Symptoms of anxiety and depression, resilience, and quality of life were assessed.

Results: Participants demonstrated significant improvements in symptoms of anxiety (P=.02) and depression (P=.03) after the intervention. Similar trends were observed in the intention-to-treat analysis. No significant differences were observed in resilience and quality-of-life measures. The sample comprised mostly females, making it challenging to discern the benefits of the intervention in males. Although a pre-post design is less rigorous than a controlled trial, this design was selected to observe changes in scores during a critical period.

Conclusions: e-CBT for COVID-19 is an effective and accessible treatment option. Improvements in clinical symptoms of anxiety and depression can be observed in individuals whose mental health is affected by the COVID-19 pandemic.

Trial registration: ClinicalTrials.gov NCT04476667; https://clinicaltrials.gov/study/NCT04476667.

International registered report identifier (irrid): RR2-10.2196/24913.

Keywords: COVID-19; anxiety; cognitive behavioral therapy; depression; efficacy; electronic cognitive behavioral therapy; evidence-based treatment; mental health; online; online psychotherapy tool; pandemic.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anxiety / therapy
  • Anxiety Disorders / therapy
  • COVID-19* / epidemiology
  • Cognitive Behavioral Therapy* / methods
  • Communicable Disease Control
  • Depression / therapy
  • Depressive Disorder, Major* / psychology
  • Female
  • Humans
  • Male
  • Mindfulness*
  • Pandemics
  • Pilot Projects
  • Quality of Life

Associated data

  • ClinicalTrials.gov/NCT04476667